- Home
- TAOP vs QNRX Comparison
TAOP vs QNRX Comparison
Compare TAOP & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAOP
- QNRX
- Stock Information
- Founded
- TAOP 1993
- QNRX 2018
- Country
- TAOP China
- QNRX United States
- Employees
- TAOP N/A
- QNRX N/A
- Industry
- TAOP Computer Software: Prepackaged Software
- QNRX Medical/Dental Instruments
- Sector
- TAOP Technology
- QNRX Health Care
- Exchange
- TAOP Nasdaq
- QNRX Nasdaq
- Market Cap
- TAOP 3.3M
- QNRX 2.7M
- IPO Year
- TAOP N/A
- QNRX N/A
- Fundamental
- Price
- TAOP $0.32
- QNRX $0.32
- Analyst Decision
- TAOP
- QNRX Strong Buy
- Analyst Count
- TAOP 0
- QNRX 1
- Target Price
- TAOP N/A
- QNRX $4.00
- AVG Volume (30 Days)
- TAOP 983.2K
- QNRX 4.1M
- Earning Date
- TAOP 09-05-2024
- QNRX 03-12-2025
- Dividend Yield
- TAOP N/A
- QNRX N/A
- EPS Growth
- TAOP N/A
- QNRX N/A
- EPS
- TAOP 0.50
- QNRX N/A
- Revenue
- TAOP $42,636,173.00
- QNRX N/A
- Revenue This Year
- TAOP N/A
- QNRX N/A
- Revenue Next Year
- TAOP N/A
- QNRX N/A
- P/E Ratio
- TAOP $0.50
- QNRX N/A
- Revenue Growth
- TAOP 37.49
- QNRX N/A
- 52 Week Low
- TAOP $0.23
- QNRX $0.28
- 52 Week High
- TAOP $1.39
- QNRX $6.18
- Technical
- Relative Strength Index (RSI)
- TAOP 54.56
- QNRX 38.39
- Support Level
- TAOP $0.28
- QNRX $0.30
- Resistance Level
- TAOP $0.34
- QNRX $0.35
- Average True Range (ATR)
- TAOP 0.03
- QNRX 0.04
- MACD
- TAOP 0.01
- QNRX 0.01
- Stochastic Oscillator
- TAOP 75.50
- QNRX 17.24
About TAOP Taoping Inc.
Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.